Bedaquiline: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Bedaquiline. Educational only — not medical advice.
Labeled uses
SIRTURO is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (2 years and older and weighing at least 8 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampin and isoniazid.
Source: FDA labeling via NIH DailyMed (set 1534c9ae…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.